JAMIESON WELLNESS INC.

Research JAMIESON WELLNESS INC. (2JW) on Bullrun: valuation model: 9.5% overvalued, market cap EUR 1.03B, P/E 23.2, dividend yield 2.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks JAMIESON WELLNESS INC. as 9.5% overvalued; latest market cap is EUR 1.03B; P/E is 23.2; dividend yield is 2.3%.

About JAMIESON WELLNESS INC.

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products.

Frequently asked questions

Is JAMIESON WELLNESS INC. overvalued or undervalued?

Bullrun's valuation model currently marks JAMIESON WELLNESS INC. as 9.5% overvalued.

What is JAMIESON WELLNESS INC.'s market cap?

JAMIESON WELLNESS INC.'s market capitalization is EUR 1.03B.

What is JAMIESON WELLNESS INC.'s P/E ratio?

JAMIESON WELLNESS INC.'s price-to-earnings (P/E) ratio is 23.2.

Does JAMIESON WELLNESS INC. pay a dividend?

JAMIESON WELLNESS INC. has a dividend yield of 2.3%.

What does JAMIESON WELLNESS INC. do?

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners.